Therefore, ARID1A may function as a tumor suppressor in cholangiocarcinoma through the transcriptional downregulation of ALDH1A1, along with a decrease in the levels of histone H3K27 acetylation (79). Here, ARID1A is linked to cholangiocarcinoma.